Rong Lu

Rong Lu

Auto-generated profile, based on publicly available information

Rong Lu

Department of Stem Cell Biology and Regenerative Medicine, Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2019 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
RLRong Lu
Rong Lu
ACAgnieszka Czechowicz
Agnieszka Czechowicz
JSJun Seita
Jun Seita
DJDu Jiang
Du Jiang
IWIrving L. Weissman
Irving L. Weissman
Significance: Hematopoietic stem cells (HSCs) are the key therapeutic component of bone marrow transplantation, the first and most prevalent clinical stem cell therapy. HSCs sustain daily and life-long blood and immune production through a complex stepwise lineage commitment process. In this work, we analyzed HSC lineage commitment at the clonal level and identified HSC regulatory mechanisms that are undetectable by conventional population-level studies. We uncovered distinct HSC clonal pathways that lead to differential blood production and imbalances. Furthermore, we showed that regulation of HSCs transplanted into unconditioned hosts is strikingly different from that after irradiation and after an antagonistic antibody treatment, which has important implications for understanding, interpreting, and optimizing HSC transplantation.

16 March 2017 in Blood
Verified
Journal Article
Closed access
PDF file
SKSamson J. Koelle
Samson J. Koelle
DEDiego A. Espinoza
Diego A. Espinoza
CWChuanfeng Wu
Chuanfeng Wu
JXJason Xu
Jason Xu
RLRong Lu
Rong Lu
CDCynthia E. Dunbar
Cynthia E. Dunbar
Autologous transplantation of hematopoietic stem and progenitor cells lentivirally labeled with unique oligonucleotide barcodes flanked by sequencing primer targets enables quantitative assessment of the self-renewal and differentiation patterns of these cells in a myeloablative rhesus macaque model. Compared with other approaches to clonal tracking, this approach is highly quantitative and reproducible. We documented stable multipotent long-term hematopoietic clonal output of monocytes, granulocytes, B cells, and T cells from a polyclonal pool of hematopoietic stem and progenitor cells in 4 macaques observed for up to 49 months posttransplantation. A broad range of clonal behaviors characterized by contribution level and biases toward certain cell types were extremely stable over time. Correlations between granulocyte and monocyte clonalities were greatest, followed by correlations between these cell types and B cells. We also detected quantitative expansion of T cell–biased clones consistent with an adaptive immune response. In contrast to recent data from a nonquantitative murine model, there was little evidence for clonal succession after initial hematopoietic reconstitution. These findings have important implications for human hematopoiesis, given the similarities between macaque and human physiologies. Publisher9s Note: There is an Inside Blood Commentary on this article in this issue. Key Points Output from individual rhesus macaque hematopoietic stem and progenitor cells is stable for years, with little evidence of clonal succession. Individual clones may display stable myeloid or lymphoid bias for many years.

30 November 2018 in Science Immunology
Verified
Journal Article
Closed access
CWChuanfeng Wu
Chuanfeng Wu
DEDiego A. Espinoza
Diego A. Espinoza
SKSamson J. Koelle
Samson J. Koelle
DYDi Yang
Di Yang
LTLauren Truitt
Lauren Truitt
CDCynthia E. Dunbar
Cynthia E. Dunbar
Macaque barcoding reveals NK oligoclonal expansion and persistence independent of production from HSPCs or immature NK cells.

4 March 2020 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
CBCharles Bramlett
Charles Bramlett
DJDu Jiang
Du Jiang
ANAnna Nogalska
Anna Nogalska
JEJiya Eerdeng
Jiya Eerdeng
JCJorge Contreras
Jorge Contreras
RLRong Lu
Rong Lu

11 November 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HCHumberto Contreras-Trujillo
Humberto Contreras-Trujillo
JEJiya Eerdeng
Jiya Eerdeng
SASamir Akre
Samir Akre
DJDu Jiang
Du Jiang
JCJorge Contreras
Jorge Contreras
RLRong Lu
Rong Lu
Cellular heterogeneity is a major cause of treatment resistance in cancer. Despite recent advances in single-cell genomic and transcriptomic sequencing, it remains difficult to relate measured molecular profiles to the cellular activities underlying cancer. Here, we present an integrated experimental system that connects single cell gene expression to heterogeneous cancer cell growth, metastasis, and treatment response. Our system integrates single cell transcriptome profiling with DNA barcode based clonal tracking in patient-derived xenograft models. We show that leukemia cells exhibiting unique gene expression respond to different chemotherapies in distinct but consistent manners across multiple mice. In addition, we uncover a form of leukemia expansion that is spatially confined to the bone marrow of single anatomical sites and driven by cells with distinct gene expression. Our integrated experimental system can interrogate the molecular and cellular basis of the intratumoral heterogeneity underlying disease progression and treatment resistance.

1 May 2016 in Cell Reports
Verified
Journal Article
Open access
CBCasey Brewer
Casey Brewer
ECElizabeth Chu
Elizabeth Chu
MCMike Chin
Mike Chin
RLRong Lu
Rong Lu
Hematopoietic stem cell (HSC) transplantation is the most prevalent stem cell therapy, but it remains a risky procedure. To improve this treatment, it is important to understand how transplanted stem cells rebuild the blood and immune systems and how this process is impacted by transplantation variables such as the HSC dose. Here, we find that, in the long term following transplantation, 70%-80% of donor-HSC-derived clones do not produce all measured blood cell types. High HSC doses lead to more clones that exhibit balanced lymphocyte production, whereas low doses produce more T-cell-specialized clones. High HSC doses also produce significantly higher proportions of early-differentiating clones compared to low doses. These complex differentiation behaviors uncover the clonal-level regeneration dynamics of hematopoietic regeneration and suggest that transplantation dose can be exploited to improve stem cell therapy.